Glycogen storage disease type I historical perspective: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Glycogen storage disease type I}} | {{Glycogen storage disease type I}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
==Historical Perspective== | ==Historical Perspective== | ||
*In 1952, Gerty T. Cori and Carl F. Cori were the first to discover the association between deficiency of glucose-6-phosphatase and type I glycogen storage disease. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 16:13, 23 October 2017
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I historical perspective On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I historical perspective |
FDA on Glycogen storage disease type I historical perspective |
CDC on Glycogen storage disease type I historical perspective |
Glycogen storage disease type I historical perspective in the news |
Blogs on Glycogen storage disease type I historical perspective |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Historical Perspective
- In 1952, Gerty T. Cori and Carl F. Cori were the first to discover the association between deficiency of glucose-6-phosphatase and type I glycogen storage disease.